Andrea Giustina

Johannes D. Veldhuis

This text presents the proceedings of an international symposium held from October 22-25 in Naples, Florida. The proceedings provide insights and concepts gained by molecular, cellular and neuroendocrine research into mechanistic interactions of the reproductive and somatotrophic axes. Chapters include discussions of the impact of sex steroids on growth hormone secretion in both children and adults sex steroids, growth hormone releasing factor, and how sex steroids modulate growth hormone action on target issues and differential effects of growth hormone secretagogues in men and women. This volume is designed for physicians, scientists and other health professionals interested or trained in clinical and basic endocrinology, growth or reproduction.

Sex-steroid Interactions with Growth Hormone

Simon R. Saunders

Stuart Carlaw

Ravi Rai Bhat

V. Srinivasa Rao

Rasa Siegberg

Femtocells are low-power wireless access points used in the home and office. They operate in licensed spectrum to connect standard mobile phones (WCDMA, LTE, WiMAX, CDMA and GSM) and other mobile devices to a mobile operator’s network via standard broadband internet connections. This technology is of high interest for mobile operators and for millions of users who will benefit from enhanced access to mobile broadband services. Femtocells outlines how wireless access points can be used by mobile operators to provide high-speed wireless access, enhancing coverage and capacity and delivering entirely new services, while maximising the benefits of licensed spectrum. The book examines the market, exploring commercial and technical factors which are critical in the initial deployment and long-term success of femtocells. Business, standards and regulatory aspects are also considered to provide a complete but concise overview. One of the first authoritative texts to concentrate on femtocells Written by expert authors from industry including leading analysts, femtocell and system vendors Covers both technology and business aspects in detail Provides overview of the relevant standards across WCDMA, LTE, CDMA, WiMAX and GSM air interfaces

Opportunities and Challenges for Business and Technology

Femtocells

Growth Hormone and the Heart endeavors to bring together knowledge that has been accumulated in the area of GH and the heart, from basic to clinical studies, by research groups working on this topic throughout the world. Lessons from different experimental models and from several human diseases (acromegaly, adult GH deficiency, heart failure) suggest to endocrinologists and cardiologists that GH may not only have a role in the physiology and pathophysiology of heart function, but that GH itself may have a place in the treatment of primary heart diseases (such as dilated cardiomyopathy) or of cardiac complications of hypopituitarism. Growth Hormone and the Heart will be a useful update of the research produced in the field of cardiovascular endocrinology. The Editors also hope that this book will serve as the primary step in the recognition of the wide physiological and clinical significance of GH and heart interactions.

Growth Hormone And The Heart

Alberto Angeli

Ernesto Canalis

Osteoporosis is one of the most clinically relevant disabling chronic disease encountered in clinical practice. A common cause of osteoporosis is glucocorticoid excess, as glucocorticoids may increase bone resorption, inhibit bone formation, have indirect actions on bone by decreasing intestinal calcium absorption and induce hypercalciuria. This book presents a comprehensive overview of the effects of glucocorticoids on bone metabolism and structure and on the diagnosis and treatment of glucocorticoid-induced osteoporosis. It aims at providing updated information on the pathogenesis, diagnosis and treatment of this often dramatic complication of glucocorticoid excess. Being one of the few publications completely devoted to glucocorticoid-induced osteoporosis it will heighten the awareness of specialists who prescribe glucocorticoids of the clinical relevance of this treatment complication. 'Glucocorticoid-Induced Osteoporosis' is addressed to clinical experts as well as to general practitioners who will both benefit from the comprehensive and integrative view of the management of patients exposed to glucocorticoids.

Glucocorticoid-induced Osteoporosis

John P. Bilezikian

F. Guaraldi

Vitamin D in Clinical Medicine

Andrea Giustina

About

Books

Join the club